Effect of Curcumin supplement on disease activity in patients with liver cirrhosis
Phase 3
Recruiting
- Conditions
- iver Cirrhosis.Fibrosis and cirrhosis of liver
- Registration Number
- IRCT20180802040678N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
MELD Score below 18
PaO2 upper than 60 mmHg
without Hepato Cellular Carcinoma
Without Hepato pulmonary syndrome
Without consumption of antiplatelet and anti coagulant drugs
Without Cholelithiasis and Bladder stone
Exclusion Criteria
MELD Score above 18
PaO2 less than 60 mmHg
Hepato pulmonary syndrome
Pulmonary artery pressure above 25mmHg
Hyper Oxaluria
Hillar cholangio carcinoma
Cystic fibrosis with FEV1 less than 40%
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method